Franchisee dependence
A substantial portion of revenue comes from royalties based on franchisee sales, so weaker clinic economics directly reduce company revenue.
- Scope
- Royalty and fee revenue
- Materiality
- high
JOINT Corp
JOINT Corp operates a franchised chiropractic care system in the United States under the THE JOINT CHIROPRACTIC brand. It earns revenue from franchise fees, royalties, software and support fees, and from a smaller base of company-owned or managed clinics while it shifts toward a more asset-light refranchising model.
1,5 %
79,6 %
5,3 %
+5,2 %
1.59
1.59
| % | |
|---|---|
| Franchise royalties and fees | 55% Recurring royalties, initial franchise fees, and related franchise support revenue from clinic operators. |
| Company-owned or managed clinics | 20% Patient service revenue from clinics the company owns or manages directly in the U.S. |
| Software and support services | 10% Monthly software, computer support, and internet services fees charged to franchisees. |
| Advertising and other clinic-related revenue | 10% Advertising fund revenue, merchant income, and other clinic-level ancillary revenue. |
| Regional developer arrangements | 5% Fees and economics tied to exclusive territories and regional development agreements. |
The core customers are franchisees and regional developers that buy the right to operate clinics under The Joint brand...
- Franchise operatorsprimary
Buy clinic licenses, training, software, and ongoing support to run chiropractic clinics under the brand.
- Regional developersprimary
Buy exclusive geographic territories and commit to opening clinics within those markets.
- Patientsprimary
Purchase chiropractic services and memberships at company-owned and franchised clinics because of convenience and low-cost access.
- Multi-unit operators and PE buyerssecondary
Acquire refranchised clinic clusters to operate larger market-based portfolios.
JOINT Corp operates primarily in the United States, where its franchised and company-owned clinics are located...
- •United States is the core operating market
- •Clinic clusters are marketed by geographic region
- •Southern California is the largest remaining corporate cluster
- •Local density improves advertising efficiency and brand awareness
- •Geography affects refranchising speed and buyer interest
The company is focused on growing through additional franchise sales and refranchising its remaining company-owned or...
01
Refranchise the corporate clinic portfolioshort-term
Moves the company toward an asset-light model and unlocks capital from owned clinics.
02
Expand franchise developmentmedium-term
More franchised clinics increase royalty, software, and advertising fee revenue.
03
Improve unit economics and brand densitymedium-term
Higher local density supports marketing efficiency and stronger same-store sales.
The business depends heavily on franchisee performance, brand reputation, and the legal treatment of...
Joint employer liability
Broader federal or state definitions could make the company liable for franchisee labor violations and collective bargaining obligations.
- Scope
- Franchise model and labor law
- Materiality
- high
Brand and reputation damage
The brand is central to patient traffic and franchise sales, so negative publicity or service quality issues can hurt demand.
- Scope
- Patient volumes and franchise growth
- Materiality
- high
Intellectual property disputes
Trademark and brand protection are important to differentiation in a fragmented market, and litigation can be costly.
- Scope
- Trademarks and brand names
- Materiality
- medium
Cybersecurity and data privacy
Clinic operations and patient data handling create compliance exposure under evolving privacy laws.
- Scope
- IT systems and patient information
- Materiality
- medium
Franchise fee revenue recognition
Smoother revenue recognition over 10-year franchise terms
Deferred revenue from memberships and wellness packages
Contract liability balance and quarterly revenue timing
Goodwill and intangible asset impairment
Potential noncash charges to operating results
Long-lived asset impairment
Possible material impairment expense
Refranchising and disposal accounting
Period-to-period comparability and adjusted EBITDA
: 28.4.2026